Artwork

Content provided by More Than Pink Podcast and Susan G. Komen Austin. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by More Than Pink Podcast and Susan G. Komen Austin or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

Eliminating Chemotherapy - TailorX Study Results. Dr. Joseph Sparano Series 2/Episode 8

29:51
 
Distribuie
 

Manage episode 238165216 series 1551136
Content provided by More Than Pink Podcast and Susan G. Komen Austin. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by More Than Pink Podcast and Susan G. Komen Austin or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Chemotherapy has been a gold standard for treatment of breast cancer and often over-treats women who may not need this aggressive treatment to treat their breast cancer. Dr. Sparano serves as the study chair for the TAILORx clinical trial sponsored by National Cancer Institute, the first clinical trial integrating a mulitparameter gene expression assay in clinical decision making for adjuvant therapy with early stage ER-positive, HER2 negative breast cancer. The results will eliminate the use of chemotherapy for thousands of women.
  continue reading

6 episoade

Artwork
iconDistribuie
 
Manage episode 238165216 series 1551136
Content provided by More Than Pink Podcast and Susan G. Komen Austin. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by More Than Pink Podcast and Susan G. Komen Austin or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Chemotherapy has been a gold standard for treatment of breast cancer and often over-treats women who may not need this aggressive treatment to treat their breast cancer. Dr. Sparano serves as the study chair for the TAILORx clinical trial sponsored by National Cancer Institute, the first clinical trial integrating a mulitparameter gene expression assay in clinical decision making for adjuvant therapy with early stage ER-positive, HER2 negative breast cancer. The results will eliminate the use of chemotherapy for thousands of women.
  continue reading

6 episoade

All episodes

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință